Back to top

AxoGen price target raised to $55 from $50 at Jefferies

Jefferies analyst Michael Sarcone raised the firm’s price target on AxoGen (AXGN) to $55 from $50 and keeps a Buy rating on the shares after a “bea...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AxoGen, Inc. (AXGN)